지혈제 시장 : 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global hemostats market size is expected to reach USD 6.82 Billion in 2034 from USD 3.69 Billion in 2025, growing at a CAGR of 7.07 during 2026-2034.This market is advancing as surgical procedures and trauma care demand effective bleeding control solutions. Hemostats are medical devices and agents used to stop bleeding during surgeries and emergencies. The increasing number of surgical procedures and the growing focus on patient safety are contributing to market growth. Healthcare providers are adopting advanced hemostatic products to improve outcomes and reduce complications.

Key drivers include advancements in medical technology, increasing healthcare expenditure, and the rising prevalence of chronic diseases requiring surgical intervention. Hemostats are widely used in hospitals, ambulatory surgical centers, and emergency care settings. The development of biocompatible and absorbable materials is enhancing product performance. Additionally, the growth of minimally invasive procedures is supporting market demand.

Future prospects remain strong, with continuous innovation in hemostatic agents and devices. The development of faster-acting and more efficient products will improve surgical outcomes. Emerging markets are expected to offer significant growth opportunities due to improving healthcare infrastructure. As demand for advanced surgical solutions increases, the hemostats market is poised for sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

• Thrombin Based Hemostats
• Oxidized Regenerated Cellulose Based Hemostats
• Combination Hemostats
• Others

By Formulation

• Matrix & Gel Hemostats
• Sponge Hemostats
• Powder Hemostats
• Others

By Application

• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Others

By End-use

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Casualty Care Centers
• Others

COMPANIES PROFILED

• Johnson & Johnson, CryoLife, Inc (Artivion), Integra LifeSciences Corporation, Pfizer, B. Braun Melsungen AG, Becton, Dickinson, and Company, Medtronic, Baxter, Stryker Corporation, Teleflex Inc., Towne Brothers Pvt. Ltd., World Precision Instruments, Ydm Corp.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEMOSTATS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Thrombin Based Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Oxidized Regenerated Cellulose Based Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Combination Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEMOSTATS MARKET: BY FORMULATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Formulation
• 5.2. Matrix & Gel Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Sponge Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Powder Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEMOSTATS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Orthopedic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. General Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Neurological Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Cardiovascular Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEMOSTATS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Casualty Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HEMOSTATS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Formulation
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Formulation
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Formulation
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Formulation
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Formulation
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HEMOSTATS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Johnson & Johnson
  • 10.2.2 CryoLife, Inc (Artivion)
  • 10.2.3 Integra LifeSciences Corporation
  • 10.2.4 Pfizer
  • 10.2.5 B. Braun Melsungen AG
  • 10.2.6 Becton, Dickinson, And Company
  • 10.2.7 Medtronic
  • 10.2.8 Baxter
  • 10.2.9 Stryker Corporation
  • 10.2.10 Teleflex Inc
  • 10.2.11 Towne Brothers Pvt. Ltd
  • 10.2.12 World Precision Instruments
  • 10.2.13 Ydm Corp